DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $340,000 | +1.5% | 1,510 | 0.0% | 0.04% | -6.7% |
Q4 2020 | $335,000 | -8.5% | 1,510 | -11.2% | 0.04% | -18.2% |
Q3 2020 | $366,000 | +21.6% | 1,700 | 0.0% | 0.06% | +12.2% |
Q2 2020 | $301,000 | +28.1% | 1,700 | 0.0% | 0.05% | +8.9% |
Q1 2020 | $235,000 | -10.0% | 1,700 | 0.0% | 0.04% | +18.4% |
Q4 2019 | $261,000 | +6.1% | 1,700 | 0.0% | 0.04% | -2.6% |
Q3 2019 | $246,000 | +1.2% | 1,700 | 0.0% | 0.04% | 0.0% |
Q2 2019 | $243,000 | +8.5% | 1,700 | 0.0% | 0.04% | +5.4% |
Q1 2019 | $224,000 | +2.3% | 1,700 | -19.9% | 0.04% | -5.1% |
Q4 2018 | $219,000 | -5.2% | 2,123 | 0.0% | 0.04% | +8.3% |
Q3 2018 | $231,000 | +10.5% | 2,123 | 0.0% | 0.04% | +5.9% |
Q2 2018 | $209,000 | -4.1% | 2,123 | -4.5% | 0.03% | -5.6% |
Q1 2018 | $218,000 | +5.8% | 2,223 | 0.0% | 0.04% | +12.5% |
Q4 2017 | $206,000 | -20.8% | 2,223 | -13.5% | 0.03% | -36.0% |
Q2 2016 | $260,000 | +16.6% | 2,570 | -9.3% | 0.05% | +16.3% |
Q2 2014 | $223,000 | -7.1% | 2,835 | -11.4% | 0.04% | -10.4% |
Q1 2014 | $240,000 | -4.8% | 3,200 | -2.0% | 0.05% | -5.9% |
Q4 2013 | $252,000 | – | 3,265 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
Third Point | 2,700,000 | $697,383,000 | 12.60% |
Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |